Hm what specific stocks are FLU related?
IMU - Imugene Limited (IMU) specialises in the development and commercialisation of animal health products for pigs and poultry, including vaccines and productivity enhancers. IMU also owns the worldwide rights to the Fowl Adenoviral Vector Delivery System for poultry and the Porcine Adenoviral Vector Delivery System for pigs.
BTA - Biota Holdings Limited (BTA) is an Australian based, anti-infective drug development company. They specialise in the discovery and development of pharmaceuticals, focusing on research for the treatment of viral respiratory diseases, particularly influenza.
Any others?
Thanks
MS
Hm what specific stocks are FLU related?
IMU - Imugene Limited (IMU) specialises in the development and commercialisation of animal health products for pigs and poultry, including vaccines and productivity enhancers. IMU also owns the worldwide rights to the Fowl Adenoviral Vector Delivery System for poultry and the Porcine Adenoviral Vector Delivery System for pigs.
BTA - Biota Holdings Limited (BTA) is an Australian based, anti-infective drug development company. They specialise in the discovery and development of pharmaceuticals, focusing on research for the treatment of viral respiratory diseases, particularly influenza.
Any others?
Thanks
MS
Fears that swine flu may have spread around the world have intensified amid a growing number of suspected cases as far afield as New Zealand, France, Israel and America.
WIKIPEDIANotable members Kleiner Perkins Caufield & Byers of the firm include partners John Doerr and Brook Byers, as well as high-profile individuals such as Sun Microsystems co-founder Bill Joy (who joined as partner in January 2005), former U.S. Secretary of State Colin Powell (who joined in July 2005 in the newly-created position of "strategic limited partner"), and former U.S. Vice President Al Gore, who joined as partner in November 2007 as part of a collaboration between KPCB and Gore's firm Generation Investment Management (GIM) to promote green technology, business and policy solutions. In 2008, John Gage of Sun Microsystems joined Gore as a Partner.
LOS ANGELES, April 24 (Reuters) - The swine flu outbreak is likely to benefit one of the most prolific and successful venture capital firms in the United States: Kleiner Perkins Caufield & Byers, Thomson Reuters Private Equity Week reported on Friday.
Shares of the two public companies in the firm's portfolio of eight Pandemic and Bio Defense companies -- BioCryst Pharmaceuticals (BCRX.O) and Novavax (NVAX.O) -- jumped Friday on news that the swine flu killed a reported 60 people in Mexico and has infected people in the United States.
Rumsfeld isn't the only political heavyweight benefiting from demand for Tamiflu, which is manufactured and marketed by Swiss pharma giant Roche. (Gilead receives a royalty from Roche equaling about 10% of sales.) Former Secretary of State George Shultz, who is on Gilead's board, has sold more than $7 million worth of Gilead since the beginning of 2005.
Another board member is the wife of former California Gov. Pete Wilson.
"I don't know of any biotech company that's so politically well-connected," says analyst Andrew McDonald of Think Equity Partners in San Francisco.
What's more, the federal government is emerging as one of the world's biggest customers for Tamiflu. In July, the Pentagon ordered $58 million worth of the treatment for U.S. troops around the world, and Congress is considering a multi-billion dollar purchase. Roche expects 2005 sales for Tamiflu to be about $1 billion, compared with $258 million in 2004.
Deadly swine flu could be here
FOUR suspected cases of swine flu are being tested in Australia as a top virologist warns the deadly virus is probably already here.
Perhaps this is what all those 'coffins' in some US state were for Metric...
You know all that conspiracy stuff, im sure you know what im talking about, cause i certainly dont
Cripes, 81 now dead .
BDM also ... illiquid , ugly , tightly held.....i keep ramping this sucka but no one listens .. i hold as a park and wait .
maybe worth a research but hey it probably wont suit many here as one needs patience and sneaky smaller accumulated entrys.
anyways DYOR blah blah blah
Business Description
Biota Holdings Limited (BTA) is an Australian based, anti-infective drug development company. They specialise in the discovery and development of pharmaceuticals, focusing on research for the treatment of viral respiratory diseases, particularly influenza.
Company Strategy
Biotas strategy is to continue drug discovery and product development programs in antivirals, particularly respiratory antivirals, and to release shareholder value from the processes of discovery, product development and the early clinical phases of drug development. The company is focused on anti-infectives and has developed drug candidates for the treatment of influenza, respiratory syncytial virus, rhinovirus and hepatitis C infections. In the long run, BTA intends to increase the number of projects within the company?s portfolio and to extend selected products further into clinic. This should help to improve the overall risk balance within the portfolio. Biota Holdings reported net loss of $6.49m for the year ended 30 June 2008. Revenues from ordinary activities were $44.99m, down 21% from last year. Diluted EPS was (3.5) cents compared to 11.0 cents last year. Net operating cash flow was $4.82m compared to $20.98m last year. No dividend was declared.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?